Despite the setback with its COVID-19 vaccine, the company has seen sales across its product lines increase almost 8%, Joseph Wolk said as the biopharma giant shared its first quarter results Tuesday.
Johnson & Johnson stronger today than pre-pandemic, CFO says (www.cfodive.com)
BriAnna Morris
20 Views
Comments
Loading…